This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA delays decision on first HIV prevention pill Truvada
FDA will take three more months to review Gilead Sciences request to approve Truvada for HIV prevention. The move follows updated safety information and a May expert panel recommendation, with ruling now expected by September 14.
MENTIONED IN THIS ARTICLE
Washington, D.C
Gilead Sciences
Food and Drug Administration
FDA
Gilead
Gilead Sciences Inc
Foster City
Cant
Truvada